EDITORIAL

The Coronavirus pandemic since 2019 has led to global concerns and created serious interests in controlling this outbreak. Though we have not found the absolute means to deal with this pandemic, most of us have unavoidably accepted the new normal way of life. Also researchers and academicians are cooperating in their studies to conduct relevant researches to find the solutions to the countless problems surrounding this disease.

The Journal of Chulabhorn Royal Academy (JCRA) Volume 3, Number 4 (October - December 2021), the last issue for this calendar year, is still being your academic dissimilation platform. This issue consists of “Short Term Outcomes of Patients undergoing Transcatheter Aortic Valve Replacement: Chulabhorn Cardiac Center Early Experience”, “Challenges for Cancer Care During the Coronavirus Disease 2019 Pandemic”, “Fibroblast Activation Protein Inhibitor (FAPI) PET/CT and PET/MRI: Novel Tracer for Molecular Imaging in Oncology”, “ABCD Feature Extraction for Melanoma Screening Using Image Processing: A review” and “18-Fluoroestradiol (18F-FES) PET Imaging in ER Positive Breast Cancer” etc..

We are delighted to inform you that the Thai Journal Citation Index Centre (TCI) Center has announced that the JCRA would be ranked in the Tier-1 of its index, system, during the period from June 30, 2021 to December 31, 2024. We owe much appreciation to all concerned that have made the JCRA where it stands today.

As always we are happy to invite everyone who is interested in submitting research / academic articles to continue upholding the JCRA academic standards.

Professor Nithi Mahanonda, M.D.

Chief Editor